Evidence map›Paper›PMID 24644404›Full record

ReviewMolecular vision2014

Review: R28 retinal precursor cells: the first 20 years.

Gail M Seigel

Open access · greenAbstract readHistorical ArticleReview
In one paragraph

Review in Molecular vision, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Primary Retinal Cell Cultures as a Model to Study Retina Biology.Advances in experimental medicine and biology · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gail M SeigelUniversity at Buffalo, Center for Hearing and Deafness, SUNY Eye Institute, Buffalo, NY.
University at Buffalo, State University of New York · US

Funding

TRANS-NETWORK PROJECTSU54CA143876 · NCI · CORNELL UNIVERSITY · PI SHULER, MICHAEL L · 2009 to 2014
$12.6M
Tumor initiating cells in retinoblastomaR21CA127061 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SEIGEL, GAIL M · 2008 to 2009
$392k
RETINAL CELL DIFFERENTIATION--EFFECT OF IMMORTALIZATIONR29EY010676 · NEI · UNIVERSITY OF ROCHESTER · PI SEIGEL, GAIL M · 1994 to 1998
–
NCI NIH HHS R21 CA127061NCI NIH HHS R21CA127061NCI NIH HHS U54 CA143876NCI NIH HHS U54CA143876NEI NIH HHS R29EY10676
6 · The paper itself

Abstract

The R28 retinal precursor cell line was established 20 years ago, originating from a postnatal day 6 rat retinal culture immortalized with the 12S E1A (NP-040507) gene of the adenovirus in a replication-incompetent viral vector. Since that time, R28 cells have been characterized and used for a variety of in vitro and in vivo studies of retinal cell behavior, including differentiation, neuroprotection, cytotoxicity, and light stimulation, as well as retinal gene expression and neuronal function. While no cell culture is equivalent to the intact eye, R28 cells continue to provide an important experimental system for the study of many retinal processes.

Indexed as

AnimalsCell Culture TechniquesCell LineGene Expression RegulationHistory, 20th CenturyHistory, 21st CenturyNeuroprotective AgentsNeurotoxinsRatsRetinaNeuroprotective AgentsNeurotoxins

Identifiers

PMID24644404
PMCPMC3955414
OpenAlexW7905208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.